Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases.

Mortality from upper gastrointestinal bleeding in patients with liver disease is high. The human recombinant activated factor VII is one of the suggested treatments for upper gastrointestinal bleeding in these patients.